1. "2020"
  2. "Cancer Research"
Formats
  1. Meeting Abstract (165)
  2. Journal Article (18)
  3. Editorial (1)
  4. Miscellaneous (1)
Groups
  1. Department of Medicine (120)
  2. GSK Faculty (103)
  3. Solid Tumor Oncology Division (103)
  4. Sloan Kettering Institute Postdocs (68)
  5. Human Oncology and Pathogenesis Program (64)
  6. Breast Medicine Service (58)

More Groups

People
  1. Jorge Reis-Filho (15)
  2. Mark Robson (13)
  3. Sarat Chandarlapaty (13)
  4. Pedram Razavi (12)
  5. Britta Weigelt (11)
  6. Komal Jhaveri (11)

More People

Years
  1. 2020 (185)
Publications
  1. Cancer Research (185)
Publishers
  1. American Association for Cancer Research (185)

Results (185)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Associations between genetically predicted blood protein biomarkers and pancreatic ductal adenocarcinoma risk
    Meeting Abstract

    Zhu, J.; Shu, X.; Guo, X.; Liu, D.; Bao, J.; Milne, R.; Giles, G. G.; Wu, C.; Du, M.; White, E.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • CHD1-loss confers AR targeted therapy resistance via promoting cancer heterogeneity and lineage plasticity
    Meeting Abstract

    Zhang, Z.; Zhou, C.; Li, X.; Barnes, S.; Deng, S.; Hoover, E.; Chen, C. C.; Lee, Y. S.; Wang, C.; Tirado, C.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • RAF dimer inhibitor lifirafenib enhances the antitumor activity of MEK inhibitor mirdametinib in RAS mutant tumors
    Meeting Abstract

    Yuan, X.; Zhang, X.; Du, R.; Cheung, S. H.; Wei, M.; Zhou, C.; Wang, L.; Shearer, T.; Edris, B.; Smith, M.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A multicenter randomized phase 2 trial of atezolizumab as monotherapy or in combination with cobimetinib in biliary tract cancers (BTCs): A NCI Experimental Therapeutics Clinical Trials Network (ETCTN) study
    Meeting Abstract

    Yarchoan, M.; Cope, L.; Anders, R. A.; Noonan, A.; Goff, L. W.; Goyal, L.; Lacy, J.; Li, D.; Patel, A.; He, A. R.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • A noncanonical histone target of NSD2 may contribute to oncogenesis
    Meeting Abstract

    Weiss, N.; Luo, M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Strategies to improve the sensitivity and ranking ability of neoantigen prediction methods: Report on the results of the Tumor nEoantigen SeLection Alliance (TESLA)
    Meeting Abstract

    Wells, D. K.; Dang, K.; Hubbard-Lucey, V. M.; Sheehan, K. C.; Lamb, A.; Ward, J. P.; Sidney, J.; Blazquez, A. B.; Rech, A. J.; Zaretsky, J.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • UGP2 is a critical regulator of protein glycosylation in pancreatic cancer
    Meeting Abstract

    Wolfe, A. L.; Galeas, J.; Toska, E.; Zhou, Q.; Ku, A.; Koche, R. P.; Bandyopadhyay, S.; Lebrilla, C. B.; Scaltriti, M.; McCormick, F.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • Rapid non-uniform adaptation to conformation-specific KRAS G12Cinhibition
    Meeting Abstract

    Xue, J. Y.; Zhao, Y.; Aronowitz, J.; Mai, T. T.; Vides, A.; Qeriqi, B.; Kim, D.; Li, C.; de Stanchina, E.; Mazutis, L.; more...
    Cancer Research (2020)

    Fulltext@MSK | Save
  • STK11 and KEAP1 co-mutation cooperatively promotes rapid tumor growth in lung adenocarcinoma
    Meeting Abstract

    Wohlhieter, C. A.; Richards, A. L.; Poirier, J. T.; Uddin, F.; Hulton, C.; De Stanchina, E.; Papagiannakopoulos, T.; Sen, T.; Rudin, C. M.
    Cancer Research (2020)

    Fulltext@MSK | Save
  • RNAi rat models for drug discovery
    Meeting Abstract

    Wang, C. L.; Yang, Y. T.; Vasileva, A.; Maurice, A.; Dow, L.; Zuber, J.; Lowe, S.; Premsrirut, P. K.
    Cancer Research (2020)

    Fulltext@MSK | Save